Safety and efficacy on TAS-102 monotherapy in clinical practice in patients with metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Kotani, Daisuke [1 ]
Shitara, Kohei [1 ]
Fukuoka, Shota [1 ]
Bando, Hideaki [1 ]
Okamoto, Wataru [1 ]
Kojima, Takashi [1 ]
Doi, Toshihiko [1 ]
Yoshino, Takayuki [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISS1-1-3
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [21] A novel antimetabolite: TAS-102 for metastatic colorectal cancer
    Miyamoto, Yuji
    Lenz, Heinz-Josef
    Baba, Hideo
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 355 - 365
  • [22] TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practice
    Shin, Ji Eun
    Lim, Sung Hee
    Lee, Jeeyun
    Lim, Ho Yeong
    Park, Young Suk
    Kim, Seung Tae
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [23] TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practice
    Shin, J. E.
    Cho, S.
    Lee, J.
    Kim, S. T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1443 - S1443
  • [24] Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis
    Fengxiang Huang
    Haiyan Yang
    Wenguang Bao
    Yehong Bin
    Shengsheng Zhou
    Man Wang
    Xiaoping Lv
    Clinical and Translational Oncology, 2024, 26 : 468 - 476
  • [25] Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis
    Huang, Fengxiang
    Yang, Haiyan
    Bao, Wenguang
    Bin, Yehong
    Zhou, Shengsheng
    Wang, Man
    Lv, Xiaoping
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (02): : 468 - 476
  • [26] Circulating tumor DNA (ctDNA) as an early marker to monitor clinical benefit of regorafenib and TAS-102 in patients with metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Lam, Michael
    Marie, Preeti Kanikarla
    Raghav, Kanwal Pratap Singh
    Morris, Van Karlyle
    Brown, Hiromi
    Windham, Justin
    Duose, Dzifa Yawa
    Overman, Michael J.
    Sanchez, Eduardo Vilar
    Wistuba, Ignacio Ivan
    Kipp, Peter
    Janku, Filip
    Sinha, Sudhir
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] A phase I study of TAS-102 in combination with oxaliplatin (TAS-OX) for refractory metastatic colorectal cancer (mCRC).
    Cecchini, Michael
    Kortmansky, Jeremy S.
    Lacy, Jill
    Fischbach, Neal A.
    Thumar, Jaykumar Ranchodbhai
    Sabbath, Kert D.
    Gomez, Christina M.
    Sporn, Jonathan
    Stein, Stacey
    Hochster, Howard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [28] A phase I dose-escalation study of TAS-102 in patients (pts) with refractory metastatic colorectal cancer (mCRC).
    Patel, Manish R.
    Bendell, Johanna C.
    Mayer, Robert J.
    Benedetti, Fabio M.
    Rosen, Lee S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Identification of biomarkers for TAS-102 efficacy in metastatic colorectal cancer patients based on preclinical analysis and clinical validation.
    Suenaga, Mitsukuni
    Mashima, Tetsuo
    Kawata, Naomi
    Dan, Shingo
    Wakatsuki, Takeru
    Shinozaki, Eiji
    Ichimura, Takashi
    Ogura, Mariko
    Takahari, Daisuke
    Osumi, Hiroki
    Ota, Yumiko
    Chin, Keisho
    Seimiya, Hiroyuki
    Yamaguchi, Kensei
    Yamaguchi, Toshiharu
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [30] Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
    Mayer, Robert J.
    Van Cutsem, Eric
    Falcone, Alfredo
    Yoshino, Takayuki
    Garcia-Carbonero, Rocio
    Mizunuma, Nobuyuki
    Yamazaki, Kentaro
    Shimada, Yasuhiro
    Tabernero, Josep
    Komatsu, Yoshito
    Sobrero, Alberto
    Boucher, Eveline
    Peeters, Marc
    Tran, Ben
    Lenz, Heinz-Josef
    Zaniboni, Alberto
    Hochster, Howard
    Cleary, James M.
    Prenen, Hans
    Benedetti, Fabio
    Mizuguchi, Hirokazu
    Makris, Lukas
    Ito, Masanobu
    Ohtsu, Atsushi
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (20): : 1909 - 1919
12345